Agios
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agios and other ETFs, options, and stocks.About AGIO
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology.
AGIO Key Statistics
Stock Snapshot
As of today, Agios(AGIO) shares are valued at $28.49. The company's market cap stands at 1.69B, with a P/E ratio of -3.92.
As of 2026-05-13, Agios(AGIO) stock has fluctuated between $28.08 and $28.70. The current price stands at $28.49, placing the stock +1.5% above today's low and -0.7% off the high.
Agios(AGIO) shares are trading with a volume of 229.33K, against a daily average of 1.17M.
During the past year, Agios(AGIO) stock moved between $22.24 at its lowest and $46.00 at its peak.
During the past year, Agios(AGIO) stock moved between $22.24 at its lowest and $46.00 at its peak.
AGIO News
Agios Pharmaceuticals (AGIO) announced the submission of its supplemental New Drug Application to the U.S. FDA for the U.S. accelerated approval of mitapivat, a...
Agios Pharmaceuticals (AGIO) announced that new data on mitapivat, an oral pyruvate kinase activator, will be featured in oral and poster presentations during t...
(RTTNews) - Rare disease drugmaker Agios Pharmaceuticals Inc. (AGIO) on Tuesday announced the submission of a supplemental New Drug Application, or sNDA, to the...
Analyst ratings
70%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.